nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—bone cancer	0.879	1	CbGaD
Guanfacine—Hypokinesia—Epirubicin—bone cancer	0.00115	0.00959	CcSEcCtD
Guanfacine—Cerebrovascular accident—Cisplatin—bone cancer	0.00112	0.00934	CcSEcCtD
Guanfacine—Hypokinesia—Doxorubicin—bone cancer	0.00106	0.00887	CcSEcCtD
Guanfacine—Irritability—Cisplatin—bone cancer	0.00105	0.00873	CcSEcCtD
Guanfacine—Orthostatic hypotension—Cisplatin—bone cancer	0.001	0.00836	CcSEcCtD
Guanfacine—Abdominal discomfort—Cisplatin—bone cancer	0.000909	0.00758	CcSEcCtD
Guanfacine—Nocturia—Epirubicin—bone cancer	0.000837	0.00698	CcSEcCtD
Guanfacine—Acute coronary syndrome—Cisplatin—bone cancer	0.000833	0.00695	CcSEcCtD
Guanfacine—Myocardial infarction—Cisplatin—bone cancer	0.000829	0.00691	CcSEcCtD
Guanfacine—Conjunctivitis—Cisplatin—bone cancer	0.000822	0.00685	CcSEcCtD
Guanfacine—Atrioventricular block—Epirubicin—bone cancer	0.0008	0.00667	CcSEcCtD
Guanfacine—Skin exfoliation—Methotrexate—bone cancer	0.000792	0.0066	CcSEcCtD
Guanfacine—Nocturia—Doxorubicin—bone cancer	0.000774	0.00646	CcSEcCtD
Guanfacine—Bradycardia—Cisplatin—bone cancer	0.000773	0.00644	CcSEcCtD
Guanfacine—Skin exfoliation—Epirubicin—bone cancer	0.000741	0.00618	CcSEcCtD
Guanfacine—Atrioventricular block—Doxorubicin—bone cancer	0.00074	0.00617	CcSEcCtD
Guanfacine—Visual impairment—Cisplatin—bone cancer	0.000731	0.0061	CcSEcCtD
Guanfacine—Cramps of lower extremities—Epirubicin—bone cancer	0.000713	0.00595	CcSEcCtD
Guanfacine—Eye disorder—Cisplatin—bone cancer	0.000709	0.00591	CcSEcCtD
Guanfacine—Tinnitus—Cisplatin—bone cancer	0.000708	0.0059	CcSEcCtD
Guanfacine—Skin exfoliation—Doxorubicin—bone cancer	0.000686	0.00572	CcSEcCtD
Guanfacine—Immune system disorder—Cisplatin—bone cancer	0.000686	0.00572	CcSEcCtD
Guanfacine—Alopecia—Cisplatin—bone cancer	0.000671	0.00559	CcSEcCtD
Guanfacine—Cramps of lower extremities—Doxorubicin—bone cancer	0.00066	0.0055	CcSEcCtD
Guanfacine—Renal failure acute—Methotrexate—bone cancer	0.000652	0.00544	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000638	0.00532	CcSEcCtD
Guanfacine—Muscle spasms—Cisplatin—bone cancer	0.000635	0.0053	CcSEcCtD
Guanfacine—Vascular purpura—Epirubicin—bone cancer	0.00063	0.00525	CcSEcCtD
Guanfacine—Vision blurred—Cisplatin—bone cancer	0.000623	0.00519	CcSEcCtD
Guanfacine—Cardiac failure congestive—Epirubicin—bone cancer	0.000621	0.00518	CcSEcCtD
Guanfacine—Tremor—Cisplatin—bone cancer	0.000619	0.00516	CcSEcCtD
Guanfacine—Cerebrovascular accident—Methotrexate—bone cancer	0.000614	0.00512	CcSEcCtD
Guanfacine—Lethargy—Methotrexate—bone cancer	0.000614	0.00512	CcSEcCtD
Guanfacine—Ill-defined disorder—Cisplatin—bone cancer	0.000613	0.00511	CcSEcCtD
Guanfacine—Renal failure acute—Epirubicin—bone cancer	0.00061	0.00509	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Epirubicin—bone cancer	0.000597	0.00498	CcSEcCtD
Guanfacine—Malaise—Cisplatin—bone cancer	0.000596	0.00497	CcSEcCtD
Guanfacine—Purpura—Epirubicin—bone cancer	0.000585	0.00487	CcSEcCtD
Guanfacine—Vascular purpura—Doxorubicin—bone cancer	0.000583	0.00486	CcSEcCtD
Guanfacine—Lethargy—Epirubicin—bone cancer	0.000575	0.00479	CcSEcCtD
Guanfacine—Cerebrovascular accident—Epirubicin—bone cancer	0.000575	0.00479	CcSEcCtD
Guanfacine—Cardiac failure congestive—Doxorubicin—bone cancer	0.000575	0.00479	CcSEcCtD
Guanfacine—Irritability—Methotrexate—bone cancer	0.000575	0.00479	CcSEcCtD
Guanfacine—Convulsion—Cisplatin—bone cancer	0.000572	0.00477	CcSEcCtD
Guanfacine—Renal failure acute—Doxorubicin—bone cancer	0.000565	0.00471	CcSEcCtD
Guanfacine—Pain in extremity—Epirubicin—bone cancer	0.000563	0.0047	CcSEcCtD
Guanfacine—Myalgia—Cisplatin—bone cancer	0.000562	0.00469	CcSEcCtD
Guanfacine—Anxiety—Cisplatin—bone cancer	0.000561	0.00467	CcSEcCtD
Guanfacine—Liver function test abnormal—Methotrexate—bone cancer	0.000556	0.00464	CcSEcCtD
Guanfacine—Discomfort—Cisplatin—bone cancer	0.000556	0.00463	CcSEcCtD
Guanfacine—Affect lability—Epirubicin—bone cancer	0.000555	0.00462	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000552	0.00461	CcSEcCtD
Guanfacine—Purpura—Doxorubicin—bone cancer	0.000541	0.00451	CcSEcCtD
Guanfacine—Oedema—Cisplatin—bone cancer	0.000539	0.0045	CcSEcCtD
Guanfacine—Diclofenac—CYP3A4—bone cancer	0.000533	0.506	CrCbGaD
Guanfacine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000532	0.00444	CcSEcCtD
Guanfacine—Lethargy—Doxorubicin—bone cancer	0.000532	0.00444	CcSEcCtD
Guanfacine—Tachycardia—Cisplatin—bone cancer	0.000526	0.00439	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—bone cancer	0.000521	0.495	CrCbGaD
Guanfacine—Pain in extremity—Doxorubicin—bone cancer	0.000521	0.00435	CcSEcCtD
Guanfacine—Hyperhidrosis—Cisplatin—bone cancer	0.000521	0.00435	CcSEcCtD
Guanfacine—Asthma—Methotrexate—bone cancer	0.00052	0.00434	CcSEcCtD
Guanfacine—Liver function test abnormal—Epirubicin—bone cancer	0.00052	0.00434	CcSEcCtD
Guanfacine—Abdominal pain upper—Epirubicin—bone cancer	0.000515	0.00429	CcSEcCtD
Guanfacine—Orthostatic hypotension—Epirubicin—bone cancer	0.000515	0.00429	CcSEcCtD
Guanfacine—Affect lability—Doxorubicin—bone cancer	0.000513	0.00428	CcSEcCtD
Guanfacine—Hypotension—Cisplatin—bone cancer	0.000504	0.0042	CcSEcCtD
Guanfacine—Abdominal discomfort—Methotrexate—bone cancer	0.000499	0.00416	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000497	0.00414	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000491	0.0041	CcSEcCtD
Guanfacine—Dysphagia—Epirubicin—bone cancer	0.000487	0.00406	CcSEcCtD
Guanfacine—Asthma—Epirubicin—bone cancer	0.000487	0.00406	CcSEcCtD
Guanfacine—Paraesthesia—Cisplatin—bone cancer	0.000484	0.00404	CcSEcCtD
Guanfacine—Liver function test abnormal—Doxorubicin—bone cancer	0.000481	0.00401	CcSEcCtD
Guanfacine—Dyspnoea—Cisplatin—bone cancer	0.000481	0.00401	CcSEcCtD
Guanfacine—Erectile dysfunction—Methotrexate—bone cancer	0.000479	0.004	CcSEcCtD
Guanfacine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000476	0.00397	CcSEcCtD
Guanfacine—Abdominal pain upper—Doxorubicin—bone cancer	0.000476	0.00397	CcSEcCtD
Guanfacine—Decreased appetite—Cisplatin—bone cancer	0.000469	0.00391	CcSEcCtD
Guanfacine—Drowsiness—Methotrexate—bone cancer	0.000464	0.00387	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00046	0.00383	CcSEcCtD
Guanfacine—Conjunctivitis—Methotrexate—bone cancer	0.000451	0.00376	CcSEcCtD
Guanfacine—Asthma—Doxorubicin—bone cancer	0.000451	0.00376	CcSEcCtD
Guanfacine—Dysphagia—Doxorubicin—bone cancer	0.000451	0.00376	CcSEcCtD
Guanfacine—Pollakiuria—Epirubicin—bone cancer	0.00045	0.00375	CcSEcCtD
Guanfacine—Sweating—Methotrexate—bone cancer	0.000445	0.00371	CcSEcCtD
Guanfacine—Feeling abnormal—Cisplatin—bone cancer	0.000444	0.00371	CcSEcCtD
Guanfacine—Weight increased—Epirubicin—bone cancer	0.000443	0.0037	CcSEcCtD
Guanfacine—Drowsiness—Epirubicin—bone cancer	0.000434	0.00362	CcSEcCtD
Guanfacine—Conjunctivitis—Epirubicin—bone cancer	0.000422	0.00352	CcSEcCtD
Guanfacine—Sweating—Epirubicin—bone cancer	0.000416	0.00347	CcSEcCtD
Guanfacine—Pollakiuria—Doxorubicin—bone cancer	0.000416	0.00347	CcSEcCtD
Guanfacine—Weight increased—Doxorubicin—bone cancer	0.00041	0.00342	CcSEcCtD
Guanfacine—Drowsiness—Doxorubicin—bone cancer	0.000402	0.00335	CcSEcCtD
Guanfacine—Visual impairment—Methotrexate—bone cancer	0.000401	0.00335	CcSEcCtD
Guanfacine—Hypersensitivity—Cisplatin—bone cancer	0.000397	0.00331	CcSEcCtD
Guanfacine—Bradycardia—Epirubicin—bone cancer	0.000397	0.00331	CcSEcCtD
Guanfacine—Rhinitis—Epirubicin—bone cancer	0.000391	0.00326	CcSEcCtD
Guanfacine—Conjunctivitis—Doxorubicin—bone cancer	0.00039	0.00326	CcSEcCtD
Guanfacine—Eye disorder—Methotrexate—bone cancer	0.000389	0.00325	CcSEcCtD
Guanfacine—Tinnitus—Methotrexate—bone cancer	0.000388	0.00324	CcSEcCtD
Guanfacine—Asthenia—Cisplatin—bone cancer	0.000387	0.00323	CcSEcCtD
Guanfacine—Sweating—Doxorubicin—bone cancer	0.000385	0.00321	CcSEcCtD
Guanfacine—Immune system disorder—Methotrexate—bone cancer	0.000376	0.00314	CcSEcCtD
Guanfacine—Visual impairment—Epirubicin—bone cancer	0.000376	0.00313	CcSEcCtD
Guanfacine—Diarrhoea—Cisplatin—bone cancer	0.000369	0.00308	CcSEcCtD
Guanfacine—Alopecia—Methotrexate—bone cancer	0.000368	0.00307	CcSEcCtD
Guanfacine—Bradycardia—Doxorubicin—bone cancer	0.000367	0.00306	CcSEcCtD
Guanfacine—Eye disorder—Epirubicin—bone cancer	0.000364	0.00304	CcSEcCtD
Guanfacine—Tinnitus—Epirubicin—bone cancer	0.000363	0.00303	CcSEcCtD
Guanfacine—Rhinitis—Doxorubicin—bone cancer	0.000362	0.00302	CcSEcCtD
Guanfacine—Dysgeusia—Methotrexate—bone cancer	0.000355	0.00296	CcSEcCtD
Guanfacine—Immune system disorder—Epirubicin—bone cancer	0.000352	0.00294	CcSEcCtD
Guanfacine—Visual impairment—Doxorubicin—bone cancer	0.000348	0.0029	CcSEcCtD
Guanfacine—Alopecia—Epirubicin—bone cancer	0.000344	0.00287	CcSEcCtD
Guanfacine—Vomiting—Cisplatin—bone cancer	0.000343	0.00286	CcSEcCtD
Guanfacine—Vision blurred—Methotrexate—bone cancer	0.000342	0.00285	CcSEcCtD
Guanfacine—Rash—Cisplatin—bone cancer	0.00034	0.00284	CcSEcCtD
Guanfacine—Dermatitis—Cisplatin—bone cancer	0.00034	0.00283	CcSEcCtD
Guanfacine—Eye disorder—Doxorubicin—bone cancer	0.000337	0.00281	CcSEcCtD
Guanfacine—Ill-defined disorder—Methotrexate—bone cancer	0.000336	0.00281	CcSEcCtD
Guanfacine—Tinnitus—Doxorubicin—bone cancer	0.000336	0.0028	CcSEcCtD
Guanfacine—Tension—Epirubicin—bone cancer	0.000333	0.00278	CcSEcCtD
Guanfacine—Dysgeusia—Epirubicin—bone cancer	0.000332	0.00277	CcSEcCtD
Guanfacine—Nervousness—Epirubicin—bone cancer	0.00033	0.00275	CcSEcCtD
Guanfacine—Malaise—Methotrexate—bone cancer	0.000327	0.00273	CcSEcCtD
Guanfacine—Muscle spasms—Epirubicin—bone cancer	0.000326	0.00272	CcSEcCtD
Guanfacine—Immune system disorder—Doxorubicin—bone cancer	0.000326	0.00272	CcSEcCtD
Guanfacine—Vertigo—Methotrexate—bone cancer	0.000326	0.00272	CcSEcCtD
Guanfacine—Nausea—Cisplatin—bone cancer	0.00032	0.00267	CcSEcCtD
Guanfacine—Vision blurred—Epirubicin—bone cancer	0.00032	0.00267	CcSEcCtD
Guanfacine—Alopecia—Doxorubicin—bone cancer	0.000319	0.00266	CcSEcCtD
Guanfacine—Ill-defined disorder—Epirubicin—bone cancer	0.000315	0.00263	CcSEcCtD
Guanfacine—Convulsion—Methotrexate—bone cancer	0.000314	0.00262	CcSEcCtD
Guanfacine—Agitation—Epirubicin—bone cancer	0.000312	0.0026	CcSEcCtD
Guanfacine—Arthralgia—Methotrexate—bone cancer	0.000309	0.00257	CcSEcCtD
Guanfacine—Chest pain—Methotrexate—bone cancer	0.000309	0.00257	CcSEcCtD
Guanfacine—Myalgia—Methotrexate—bone cancer	0.000309	0.00257	CcSEcCtD
Guanfacine—Tension—Doxorubicin—bone cancer	0.000308	0.00257	CcSEcCtD
Guanfacine—Dysgeusia—Doxorubicin—bone cancer	0.000307	0.00256	CcSEcCtD
Guanfacine—Malaise—Epirubicin—bone cancer	0.000306	0.00255	CcSEcCtD
Guanfacine—Discomfort—Methotrexate—bone cancer	0.000305	0.00254	CcSEcCtD
Guanfacine—Nervousness—Doxorubicin—bone cancer	0.000305	0.00254	CcSEcCtD
Guanfacine—Vertigo—Epirubicin—bone cancer	0.000305	0.00254	CcSEcCtD
Guanfacine—Syncope—Epirubicin—bone cancer	0.000304	0.00254	CcSEcCtD
Guanfacine—Muscle spasms—Doxorubicin—bone cancer	0.000302	0.00252	CcSEcCtD
Guanfacine—Palpitations—Epirubicin—bone cancer	0.0003	0.0025	CcSEcCtD
Guanfacine—Confusional state—Methotrexate—bone cancer	0.000298	0.00249	CcSEcCtD
Guanfacine—Loss of consciousness—Epirubicin—bone cancer	0.000298	0.00249	CcSEcCtD
Guanfacine—Vision blurred—Doxorubicin—bone cancer	0.000296	0.00247	CcSEcCtD
Guanfacine—Convulsion—Epirubicin—bone cancer	0.000294	0.00245	CcSEcCtD
Guanfacine—Hypertension—Epirubicin—bone cancer	0.000293	0.00244	CcSEcCtD
Guanfacine—Ill-defined disorder—Doxorubicin—bone cancer	0.000291	0.00243	CcSEcCtD
Guanfacine—Chest pain—Epirubicin—bone cancer	0.000289	0.00241	CcSEcCtD
Guanfacine—Myalgia—Epirubicin—bone cancer	0.000289	0.00241	CcSEcCtD
Guanfacine—Arthralgia—Epirubicin—bone cancer	0.000289	0.00241	CcSEcCtD
Guanfacine—Agitation—Doxorubicin—bone cancer	0.000288	0.00241	CcSEcCtD
Guanfacine—Anxiety—Epirubicin—bone cancer	0.000288	0.0024	CcSEcCtD
Guanfacine—Hyperhidrosis—Methotrexate—bone cancer	0.000286	0.00239	CcSEcCtD
Guanfacine—Discomfort—Epirubicin—bone cancer	0.000285	0.00238	CcSEcCtD
Guanfacine—Malaise—Doxorubicin—bone cancer	0.000283	0.00236	CcSEcCtD
Guanfacine—Dry mouth—Epirubicin—bone cancer	0.000282	0.00236	CcSEcCtD
Guanfacine—Vertigo—Doxorubicin—bone cancer	0.000282	0.00235	CcSEcCtD
Guanfacine—Syncope—Doxorubicin—bone cancer	0.000282	0.00235	CcSEcCtD
Guanfacine—Confusional state—Epirubicin—bone cancer	0.000279	0.00233	CcSEcCtD
Guanfacine—Palpitations—Doxorubicin—bone cancer	0.000277	0.00231	CcSEcCtD
Guanfacine—Oedema—Epirubicin—bone cancer	0.000277	0.00231	CcSEcCtD
Guanfacine—Hypotension—Methotrexate—bone cancer	0.000276	0.00231	CcSEcCtD
Guanfacine—Loss of consciousness—Doxorubicin—bone cancer	0.000276	0.0023	CcSEcCtD
Guanfacine—Shock—Epirubicin—bone cancer	0.000272	0.00227	CcSEcCtD
Guanfacine—Convulsion—Doxorubicin—bone cancer	0.000272	0.00227	CcSEcCtD
Guanfacine—Hypertension—Doxorubicin—bone cancer	0.000271	0.00226	CcSEcCtD
Guanfacine—Tachycardia—Epirubicin—bone cancer	0.00027	0.00225	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00027	0.00225	CcSEcCtD
Guanfacine—Hyperhidrosis—Epirubicin—bone cancer	0.000268	0.00223	CcSEcCtD
Guanfacine—Insomnia—Methotrexate—bone cancer	0.000268	0.00223	CcSEcCtD
Guanfacine—Myalgia—Doxorubicin—bone cancer	0.000267	0.00223	CcSEcCtD
Guanfacine—Arthralgia—Doxorubicin—bone cancer	0.000267	0.00223	CcSEcCtD
Guanfacine—Chest pain—Doxorubicin—bone cancer	0.000267	0.00223	CcSEcCtD
Guanfacine—Anxiety—Doxorubicin—bone cancer	0.000266	0.00222	CcSEcCtD
Guanfacine—Paraesthesia—Methotrexate—bone cancer	0.000266	0.00222	CcSEcCtD
Guanfacine—Discomfort—Doxorubicin—bone cancer	0.000264	0.0022	CcSEcCtD
Guanfacine—Dyspnoea—Methotrexate—bone cancer	0.000264	0.0022	CcSEcCtD
Guanfacine—Somnolence—Methotrexate—bone cancer	0.000263	0.00219	CcSEcCtD
Guanfacine—Dry mouth—Doxorubicin—bone cancer	0.000261	0.00218	CcSEcCtD
Guanfacine—Dyspepsia—Methotrexate—bone cancer	0.00026	0.00217	CcSEcCtD
Guanfacine—Hypotension—Epirubicin—bone cancer	0.000259	0.00216	CcSEcCtD
Guanfacine—Confusional state—Doxorubicin—bone cancer	0.000258	0.00215	CcSEcCtD
Guanfacine—Decreased appetite—Methotrexate—bone cancer	0.000257	0.00215	CcSEcCtD
Guanfacine—Oedema—Doxorubicin—bone cancer	0.000256	0.00214	CcSEcCtD
Guanfacine—Fatigue—Methotrexate—bone cancer	0.000255	0.00213	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000252	0.0021	CcSEcCtD
Guanfacine—Shock—Doxorubicin—bone cancer	0.000252	0.0021	CcSEcCtD
Guanfacine—Insomnia—Epirubicin—bone cancer	0.00025	0.00209	CcSEcCtD
Guanfacine—Tachycardia—Doxorubicin—bone cancer	0.00025	0.00209	CcSEcCtD
Guanfacine—Paraesthesia—Epirubicin—bone cancer	0.000249	0.00207	CcSEcCtD
Guanfacine—Hyperhidrosis—Doxorubicin—bone cancer	0.000248	0.00207	CcSEcCtD
Guanfacine—Dyspnoea—Epirubicin—bone cancer	0.000247	0.00206	CcSEcCtD
Guanfacine—Somnolence—Epirubicin—bone cancer	0.000246	0.00205	CcSEcCtD
Guanfacine—Feeling abnormal—Methotrexate—bone cancer	0.000244	0.00203	CcSEcCtD
Guanfacine—Dyspepsia—Epirubicin—bone cancer	0.000244	0.00203	CcSEcCtD
Guanfacine—Gastrointestinal pain—Methotrexate—bone cancer	0.000242	0.00202	CcSEcCtD
Guanfacine—Decreased appetite—Epirubicin—bone cancer	0.000241	0.00201	CcSEcCtD
Guanfacine—Hypotension—Doxorubicin—bone cancer	0.000239	0.002	CcSEcCtD
Guanfacine—Fatigue—Epirubicin—bone cancer	0.000239	0.00199	CcSEcCtD
Guanfacine—Constipation—Epirubicin—bone cancer	0.000237	0.00197	CcSEcCtD
Guanfacine—Abdominal pain—Methotrexate—bone cancer	0.000234	0.00195	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000233	0.00195	CcSEcCtD
Guanfacine—Insomnia—Doxorubicin—bone cancer	0.000232	0.00193	CcSEcCtD
Guanfacine—Paraesthesia—Doxorubicin—bone cancer	0.00023	0.00192	CcSEcCtD
Guanfacine—Dyspnoea—Doxorubicin—bone cancer	0.000228	0.0019	CcSEcCtD
Guanfacine—Feeling abnormal—Epirubicin—bone cancer	0.000228	0.0019	CcSEcCtD
Guanfacine—Somnolence—Doxorubicin—bone cancer	0.000228	0.0019	CcSEcCtD
Guanfacine—Gastrointestinal pain—Epirubicin—bone cancer	0.000226	0.00189	CcSEcCtD
Guanfacine—Dyspepsia—Doxorubicin—bone cancer	0.000226	0.00188	CcSEcCtD
Guanfacine—Decreased appetite—Doxorubicin—bone cancer	0.000223	0.00186	CcSEcCtD
Guanfacine—Fatigue—Doxorubicin—bone cancer	0.000221	0.00184	CcSEcCtD
Guanfacine—Constipation—Doxorubicin—bone cancer	0.000219	0.00183	CcSEcCtD
Guanfacine—Abdominal pain—Epirubicin—bone cancer	0.000219	0.00183	CcSEcCtD
Guanfacine—Hypersensitivity—Methotrexate—bone cancer	0.000218	0.00182	CcSEcCtD
Guanfacine—Asthenia—Methotrexate—bone cancer	0.000212	0.00177	CcSEcCtD
Guanfacine—Feeling abnormal—Doxorubicin—bone cancer	0.000211	0.00176	CcSEcCtD
Guanfacine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00021	0.00175	CcSEcCtD
Guanfacine—Pruritus—Methotrexate—bone cancer	0.000209	0.00175	CcSEcCtD
Guanfacine—Hypersensitivity—Epirubicin—bone cancer	0.000204	0.0017	CcSEcCtD
Guanfacine—Abdominal pain—Doxorubicin—bone cancer	0.000203	0.00169	CcSEcCtD
Guanfacine—Diarrhoea—Methotrexate—bone cancer	0.000202	0.00169	CcSEcCtD
Guanfacine—Asthenia—Epirubicin—bone cancer	0.000199	0.00166	CcSEcCtD
Guanfacine—Pruritus—Epirubicin—bone cancer	0.000196	0.00163	CcSEcCtD
Guanfacine—Dizziness—Methotrexate—bone cancer	0.000196	0.00163	CcSEcCtD
Guanfacine—Diarrhoea—Epirubicin—bone cancer	0.000189	0.00158	CcSEcCtD
Guanfacine—Hypersensitivity—Doxorubicin—bone cancer	0.000189	0.00157	CcSEcCtD
Guanfacine—Vomiting—Methotrexate—bone cancer	0.000188	0.00157	CcSEcCtD
Guanfacine—Rash—Methotrexate—bone cancer	0.000187	0.00156	CcSEcCtD
Guanfacine—Dermatitis—Methotrexate—bone cancer	0.000186	0.00155	CcSEcCtD
Guanfacine—Headache—Methotrexate—bone cancer	0.000185	0.00155	CcSEcCtD
Guanfacine—Asthenia—Doxorubicin—bone cancer	0.000184	0.00153	CcSEcCtD
Guanfacine—Dizziness—Epirubicin—bone cancer	0.000183	0.00153	CcSEcCtD
Guanfacine—Pruritus—Doxorubicin—bone cancer	0.000181	0.00151	CcSEcCtD
Guanfacine—Vomiting—Epirubicin—bone cancer	0.000176	0.00147	CcSEcCtD
Guanfacine—Nausea—Methotrexate—bone cancer	0.000176	0.00147	CcSEcCtD
Guanfacine—Diarrhoea—Doxorubicin—bone cancer	0.000175	0.00146	CcSEcCtD
Guanfacine—Rash—Epirubicin—bone cancer	0.000175	0.00146	CcSEcCtD
Guanfacine—Dermatitis—Epirubicin—bone cancer	0.000174	0.00145	CcSEcCtD
Guanfacine—Headache—Epirubicin—bone cancer	0.000173	0.00145	CcSEcCtD
Guanfacine—Dizziness—Doxorubicin—bone cancer	0.000169	0.00141	CcSEcCtD
Guanfacine—Nausea—Epirubicin—bone cancer	0.000164	0.00137	CcSEcCtD
Guanfacine—Vomiting—Doxorubicin—bone cancer	0.000163	0.00136	CcSEcCtD
Guanfacine—Rash—Doxorubicin—bone cancer	0.000162	0.00135	CcSEcCtD
Guanfacine—Dermatitis—Doxorubicin—bone cancer	0.000161	0.00135	CcSEcCtD
Guanfacine—Headache—Doxorubicin—bone cancer	0.000161	0.00134	CcSEcCtD
Guanfacine—Nausea—Doxorubicin—bone cancer	0.000152	0.00127	CcSEcCtD
